PhD Metka Novak

PhD Metka Novak
no.: 32116 source: ARIS

researcher – active in research organisation
  metka.novakat signnib.si
Edit
Research activity

Code Science Field Subfield
1.05.00  Natural sciences and mathematics  Biochemistry and molecular biology   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
354.19
A''
57.91
A'
146.53
A1/2
232.26
CI10
1,020
CImax
291
h10
15
A1
1.23
A3
0.85
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2019, 2020, 2021, 2022, 2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 36  1,020  958  26.61 
Scopus 34  1,083  1,022  30.06 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Anamarija Habič   Bologna doctoral studies  10/1/2020 - 9/30/2024  54677 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
Bachelor's degree      SI University of Ljubljana, Faculty of Chemistry and Chemical Technology 2009 
Doctoral degree  Ph. D.   Biomedicine  SI University of Ljubljana, Faculty of Medicine 2014 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  National Institute of Biology  Department of Genetic Toxicology and Cancer Biology  1/1/2018  Assistant  Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head
1. BI-US/24-26-022  Exploiting MAGE proteins to combat therapy resistance of aggressive tumors   7/1/2024 - 6/30/2026  PhD Metka Novak   143 
2. J3-4504  Uncovering the glioblastoma microenvironment to enhance the therapy   10/1/2022 - 9/30/2025  PhD Metka Novak   1,982 
3. L3-3176  The Role and Potential Application of Immunomodulatory Mesenchymal Stem Cells in COVID- 19 Disease   10/1/2021 - 9/30/2024  PhD Janja Zupan   3,636 
4. NC-0023  Innovative Probes and Inhibition of Metalloproteases for Targeting Glioblastoma Stem Cells in Tumour Microenvironment   2/1/2022 - 1/31/2024  PhD Barbara Breznik   1,242 
5. J3-2516  Cystatin f as a mediator of immunosuppression in glioblastoma microenvironment   9/1/2020 - 8/31/2023  PhD Milica Perišić Nanut   2,867 
6. J3-2526  Unravelling glioma stem cell niches for novel therapeutic targets in glioblastoma patients   9/1/2020 - 8/31/2023  PhD Cornelis J.F. van Noorden   2,524 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0245  Ecotoxicology, toxicogenomics and carcinogenesis   1/1/2019 - 12/31/2027 PhD Bojana Žegura   3,065 
2. P1-0245  Ecotoxicology, toxicogenomics and carcinogenesis   1/1/2015 - 12/31/2018 PhD Tamara Lah Turnšek   3,421 
3. P1-0104  Functional genomics and biotechnology for health   1/1/2009 - 12/31/2014 PhD Radovan Komel   4,321 
Confirmation required
Views history
Favourite